Recent progress of proteomics in critical illness

Shock

Volumn 31, Issue 6, 2009, Pages 545-552

  Karvunidis, Thomas ^a   Mares, Jan ^a   Thongboonkerd, Visith ^b   Matejovic, Martin ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Biomarker; Gel electrophoresis; Intensive care; Mass spectrometry; Organ failure

Indexed keywords

BIOLOGICAL MARKER; PROTEIN; PROTEOME;

BIOTECHNOLOGY; CLINICAL EVALUATION; CRITICAL ILLNESS; HUMAN; INTENSIVE CARE UNIT; MOLECULAR GENETICS; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEOMICS; REVIEW; SEPSIS; SEPTIC SHOCK;

ANIMALS; CRITICAL ILLNESS; HUMANS; MASS SPECTROMETRY; MULTIPLE ORGAN FAILURE; PROTEOMICS;

EID: 68049113648     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181986eab     Document Type: Review

References (62)

1. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546-1554, 2003.
2. Annane D, Bellissant E, Cavaillon JM: Septic shock. Lancet 365:63-78, 2005.
3. Venter JC, Adams MD, Myers EW, et al.: The sequence of the human genome. Science 291:1304-1351, 2001.
4. Lander ES, Linton LM, Birren B, et al.: Initial sequencing and analysis of the human genome. Nature 409:860-921, 2001.
5. Hoehn GT, Suffredini AF: Proteomics. Crit Care Med 33:S444-S448, 2005.
6. MacBeath G: Protein microarrays and proteomics. Nat Genet 32(suppl): 526-532, 2002.
7. Wilkins MR, Sanchez JC, Williams KL, Hochstrasser DF: Current challenges and future applications for protein maps and post-translational vector maps in proteome projects. Electrophoresis 17:830-838, 1996.
8. Peng J, Gygi SP: Proteomics: the move to mixtures. J Mass Spectrom 36: 1083-1091, 2001.
9. de Hoog CL, Mann M: Proteomics. Annu Rev Genomics Hum Genet 5:267-293, 2004.
10. Phizicky E, Bastiaens PI, Zhu H, Snyder M, Fields S: Protein analysis on a proteomic scale. Nature 422:208-215, 2003.
11. Hanash S: Disease proteomics. Nature 422:226-232, 2003.
12. Graves PR, Haystead TA: Molecular biologist's guide to proteomics. Microbiol Mol Biol Rev 66:39-63, 2002.
13. Nguyen A, Yaffe MB: Proteomics and systems biology approaches to signal transduction in sepsis. Crit Care Med 31:S1-S6, 2003.
14. Wang X, Adler KB, Chaudry IH, Ward PA: Better understanding of organ dysfunction requires proteomic involvement. J Proteome Res 5:1060-1062, 2006.
15. Fliser D, Novak J, Thongboonkerd V, Argiles A, Jankowski V, Girolami MA, Jankowski J, Mischak H: Advances in urinary proteome analysis and biomarker discovery. J Am Soc Nephrol 18:1057-1071, 2007.
16. Liu BC, Zhang L, Lv LL, Wang YL, Liu DG, Zhang XL: Application of antibody array technology in the analysis of urinary cytokine profiles in patients with chronic kidney disease. Am J Nephrol 26:483-490, 2006.
17. Angenendt P: Progress in protein and antibody microarray technology. Drug Discov Today 10:503-511, 2005.
18. Levy RJ: Mitochondrial dysfunction, bioenergetic impairment, and metabolic down-regulation in sepsis. Shock 28:24-28, 2007.
19. Crouser ED, Julian MW, Huff JE, Mandich DV, Green-Church KB: A proteomic analysis of liver mitochondria during acute endotoxemia. Intensive Care Med 32:1252-1262, 2006.
20. Chen HW, Kuo HT, Hwang LC, Kuo MF, Yang RC: Proteomic alteration of mitochondrial aldehyde dehydrogenase 2 in sepsis regulated by heat shock response. Shock 28:710-716, 2007.
21. Ren Y, Wang J, Xia J, Jiang C, Zhao K, Li R, Xu N, Xu Y, Liu S: The alterations of mouse plasma proteins during septic development. J Proteome Res 6:2812-2821, 2007.
22. Duan X, Berthiaume F, Yarmush D, Yarmush ML: Proteomic analysis of altered protein expression in skeletal muscle of rats in a hypermetabolic state induced by burn sepsis. Biochem J 397:149-158, 2006.
23. Chang AY, Chan JY, Chou JL, Li FC, Dai KY, Chan SH: Heat shock protein 60 in rostral ventrolateral medulla reduces cardiovascular fatality during endotoxaemia in the rat. J Physiol 574:547-564, 2006.
24. Li FC, Chan JY, Chan SH, Chang AY: In the rostral ventrolateral medulla, the 70-kDa heat shock protein (HSP70), but not HSP90, confers neuroprotection against fatal endotoxemia via augmentation of nitric-oxide synthase I (NOS I)/ protein kinase G signaling pathway and inhibition of NOS II/peroxynitrite cascade. Mol Pharmacol 68:179-192, 2005.
25. Chan JY, Wang SH, Chan SH: Differential roles of iNOS and nNOS at rostral ventrolateral medulla during experimental endotoxemia in the rat. Shock 15: 65-72, 2001.
26. Holly MK, Dear JW, Hu X, Schechter AN, Gladwin MT, Hewitt SM, Yuen PS, Star RA: Biomarker and drug-target discovery using proteomics in a new rat model of sepsis-induced acute renal failure. Kidney Int 70:496-506, 2006.
27. Dear JW, Leelahavanichkul A, Aponte A, Hu X, Constant SL, Hewitt SM, Yuen PS, Star RA: Liver proteomics for therapeutic drug discovery: inhibition of the cyclophilin receptor CD147 attenuates sepsis-induced acute renal failure. Crit Care Med 35:2319-2328, 2007.
28. Grigoryev DN, Liu M, Hassoun HT, Cheadle C, Barnes KC, Rabb H: The local and systemic inflammatory transcriptome after acute kidney injury. J Am Soc Nephrol 19:547-558, 2008.
29. Reade MC, Young JD: Of mice and men (and rats): implications of species and stimulus differences for the interpretation of studies of nitric oxide in sepsis. Br J Anaesth 90:115-118, 2003.
30. Bauer M, Reinhart K: From mice and MOF: rodent models, immune modulation, and outcome in the critically ill. Crit Care Med 34:921-923, 2006.
31. Dunn MJ: Studying heart disease using the proteomic approach. Drug Discov Today 5:76-84, 2000.
32. Qian WJ, Jacobs JM, Camp DG, Monroe ME, Moore RJ, Gritsenko MA, Calvano SE, Lowry SF, Xiao W, Moldawer LL, et al.: Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry. Proteomics 5:572-584, 2005.
33. Kalenka A, Feldmann RE Jr, Otero K, Maurer MH, Waschke KF, Fiedler F: Changes in the serum proteome of patients with sepsis and septic shock. Anesth Analg 103:1522-1526, 2006.
34. Feezor RJ, Baker HV, Xiao W, Lee WA, Huber TS, Mindrinos M, Kim RA, Ruiz-Taylor L, Moldawer LL, Davis RW, et al.: Genomic and proteomic determinants of outcome in patients undergoing thoracoabdominal aortic aneurysm repair. J Immunol 172:7103-7109, 2004.
35. Kaiser T, Kamal H, Rank A, Kolb HJ, Holler E, Ganser A, Hertenstein B, Mischak H, Weissinger EM: Proteomics applied to the clinical follow-up of patients after allogeneic hematopoietic stem cell transplantation. Blood 104:340-349, 2004.
36. Buhimschi CS, Buhimschi IA, bdel-Razeq S, Rosenberg VA, Thung SF, Zhao G, Wang E, Bhandari V: Proteomic biomarkers of intra-amniotic inflammation: relationship with funisitis and early-onset sepsis in the premature neonate. Pediatr Res 61:318-324, 2007.
37. Shen Z, Want EJ, Chen W, Keating W, Nussbaumer W, Moore R, Gentle TM, Siuzdak G: Sepsis plasma protein profiling with immunodepletion, three-dimensional liquid chromatography tandem mass spectrometry, and spectrum counting. J Proteome Res 5:3154-3160, 2006.
38. Rubenfeld GD, Herridge MS: Epidemiology and outcomes of acute lung injury. Chest 131:554-562, 2007.
39. Bowler RP, Ellison MC, Reisdorph N: Proteomics in pulmonary medicine. Chest 130:567-574, 2006.
40. Schnapp LM, Donohoe S, Chen J, Sunde DA, Kelly PM, Ruzinski J, Martin T, Goodlett DR: Mining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injury. Am J Pathol 169:86-95, 2006.
41. Lameire N, Van BW, Vanholder R: Acute renal failure. Lancet 365:417-430, 2005.
42. Uchino S, Kellum JA, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, et al.: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 294:813-818, 2005.
43. Palevsky PM: Epidemiology of acute renal failure: the tip of the iceberg. Clin J Am Soc Nephrol 1:6-7, 2006.
44. Liangos O, Wald R, O'Bell JW, Price L, Pereira BJ, Jaber BL: Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey. Clin J Am Soc Nephrol 1:43-51, 2006.
45. Devarajan P: Proteomics for the Investigation of acute kidney injury. Contrib Nephrol 160:1-16, 2008.
46. Nguyen MT, Ross GF, Dent CL, Devarajan P: Early prediction of acute renal injury using urinary proteomics. Am J Nephrol 25:318-326, 2005.
47. Lefler DM, Pafford RG, Black NA, Raymond JR, Arthur JM: Identification of proteins in slow continuous ultrafiltrate by reversed-phase chromatography and proteomics. J Proteome Res 3:1254-1260, 2004.
48. Vanhoutte KJ, Laarakkers C, Marchiori E, Pickkers P, Wetzels JF, Willems JL, van den Heuvel LP, Russel FG, Masereeuw R: Biomarker discovery with SELDI-TOF MS in human urine associated with early renal injury: evaluation with computational analytical tools. Nephrol Dial Transplant 22:2932-2943, 2007.
49. Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 101:3765-3777, 2003.
50. Vallet B: Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction? Crit Care 7:130-138, 2003.
51. Boos CJ, Goon PK, Lip GY: The endothelium, inflammation, and coagulation in sepsis. Clin Pharmacol Ther 79:20-22, 2006.
52. Matsuda N, Hattori Y: Vascular biology in sepsis: pathophysiological and therapeutic significance of vascular dysfunction. J Smooth Muscle Res 43: 117-137, 2007.
53. Abraham E, Singer M: Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 35:2408-2416, 2007.
54. Karsan A, Blonder J, Law J, Yaquian E, Lucas DA, Conrads TP, Veenstra T: Proteomic analysis of lipid microdomains from lipopolysaccharide-activated human endothelial cells. J Proteome Res 4:349-357, 2005.
55. Vanderschueren S, De WA, Malbrain M, Vankersschaever D, Frans E, Wilmer A, Bobbaers H: Thrombocytopenia and prognosis in intensive care. Crit Care Med 28:1871-1876, 2000.
56. Strauss R, Wehler M, Mehler K, Kreutzer D, Koebnick C, Hahn EG: Thrombocytopenia in patients in the medical intensive care unit: bleeding prevalence, transfusion requirements, and outcome. Crit Care Med 30: 1765-1771, 2002.
57. Levi M: Platelets. Crit Care Med 33:S523-S525, 2005.
58. Maguire PB, Moran N, Cagney G, Fitzgerald DJ: Application of proteomics to the study of platelet regulatory mechanisms. Trends Cardiovasc Med 14:207-220, 2004.
59. Maguire PB, Fitzgerald DJ: Platelet proteomics. J Thromb Haemost 1:1593-1601, 2003.
60. Gnatenko DV, Perrotta PL, Bahou WF: Proteomic approaches to dissect platelet function: half the story. Blood 108:3983-3991, 2006.
61. Matejovic M, Radermacher P, Thongboonkerd V: From hemodynamics to proteomics: unraveling the complexity of acute kidney injury in sepsis. In Vincent JL, ed.: Yearbook of Intensive Care and Emergency Medicine. Berlin, Heidelberg: Springer-Verlag, 2008.
62. Shao W, Yeretssian G, Doiron K, Hussain SN, Saleh M: The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem 282:36321-36329, 2007.